Indoco Remedies informs about company updates

18 Jan 2019 Evaluate

Indoco Remedies has informed that, as informed in its quarterly MDA Synpsis, the Company was expecting re-inspection of Goa Plant I and Plant II by USFDA. Inspection of Goa PIant II (Sterile facility) was completed from 14 - 21 November, 2018 and Goa Plant I (Solid oral facility) inspection by USFDA has commenced since 17th January, 2019.

The above information is a part of company’s filings submitted to BSE.

Indoco Remedies Share Price

206.95 -1.10 (-0.53%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×